Elevance Health (ELV) Enterprise Value (2009 - 2026)

Elevance Health (ELV) has reported Enterprise Value for 18 consecutive years, with $48.0 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Enterprise Value fell 10.57% year-over-year to $48.0 billion in Q2 2026; TTM through Jun 2026 was $48.0 billion, a 10.57% decrease from a year earlier, with the FY2025 full-year figure at $42.1 billion, down 16.61% from the prior year.
• Enterprise Value was $48.0 billion for Q2 2026 at Elevance Health, up from $28.2 billion in the prior quarter.
• Over five years, Enterprise Value peaked at $90.4 billion in Q2 2024 and troughed at $28.2 billion in Q1 2026.
• A 5-year average of $66.3 billion and a median of $69.1 billion in 2023 frame the typical range for Enterprise Value.
• Across the five-year window, Enterprise Value soared 58.7% in 2022 and sank 56.81% in 2026, its largest moves.
• Over 5 years, Enterprise Value stood at $88.8 billion in 2022, then declined by 16.83% to $73.9 billion in 2023, then plunged by 31.58% to $50.5 billion in 2024, then retreated by 16.61% to $42.1 billion in 2025, then increased by 14.01% to $48.0 billion in 2026.
• The last three Enterprise Value figures came in at $48.0 billion (Q2 2026), $28.2 billion (Q1 2026), and $42.1 billion (Q4 2025), per Business Quant data.